Community navigation plus tablet education to boost mammogram screening for Navajo women
Official title: Community-led Navigation to Address Disparities in Mammography Among Native American Women
Run by Johns Hopkins Bloomberg School of Public Health · NCT06957535 · Data updated 2026-11-12
The study will try a tablet-based, culturally tailored education program called TEAM, with or without monthly one-on-one Diné peer navigation, to increase mammography screening among Navajo Nation women aged 40–74.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 74 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Johns Hopkins Bloomberg School of Public Health Academic / other |
| Locations | 1 site (Chinle, Arizona) |
| Status | Recruiting |
| Started | October 2, 2025 |
| Main results expected | August 2027 |
| Study ends | March 2028 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT06957535 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are American Indian or Alaska Native women aged 40–74 who are registered patients at Chinle Comprehensive HealthCare Facility, live within 80 miles of the clinic, have not had a mammogram in the prior 12 months, have no personal history of breast cancer, and are willing to be randomized.
✕Probably not a fit
Women who are not AI/AN, are outside the 40–74 age range, have had a mammogram in the past 12 months, have a personal history of breast cancer, are not registered at CCHCF, live more than 80 miles away, or are unwilling to be randomized are unlikely to benefit from joining this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional project compares two approaches: TEAM (tablet-based, culturally tailored mammography education) versus TEAM plus monthly 1:1 support from a Diné peer navigator. TEAM content was developed through community-based participatory methods to reflect local cultural context. Eligible participants are AI/AN women aged 40–74 who are registered patients at Chinle Comprehensive HealthCare Facility and have not had a mammogram in the past 12 months. The trial is conducted at the Navajo Nation Center for Indigenous Health in Chinle, Arizona and uses random assignment to measure differences in screening uptake.
Why it matters
Potential benefit: If successful, the intervention could raise mammography screening rates and help detect breast cancer earlier among Navajo women.
How similar studies have gone: Previous navigation and culturally tailored education programs have improved cancer screening in underserved populations, but this specific TEAM plus Diné peer-navigation approach on the Navajo Nation is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as American Indian or Alaska Native (AIAN) * Identify as Female * Are 40-74 years of age * Are a registered patient at Chinle Comprehensive HealthCare Facility (CCHFC) * Live within 80 miles of CCHFC * Have not received a mammogram within the prior 12 months * Do not have a personal history of breast cancer * Are not planning to move in the next 6 months * Willing to be randomized Exclusion Criteria: * Do not self-identify as American Indian or Alaska Native (AIAN) * Do not identify as Female * Are not 40-74 years of age * Are not a registered patient at CCHCF * Do not live within 80 miles of CCHCF * Have received a mammogram within the prior 12 months * Have a personal history of breast cancer * Are planning to move in the next 6 months * Unwilling to be randomized
Where it's running
-
Navajo Nation Center for Indigenous Health
Chinle, Arizona, United States Recruiting
Study contacts
- Principal investigator: Katie Nelson, PhD — Johns Hopkins University
- Study coordinator: Katie Nelson, PhD
- Email: knelso46@jhmi.edu
- Phone: 410-955-6931
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.